Publication

Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing

March 22, 2024
ActivityScan Assay
Burst Detection
Calcium Imaging
Disease Modeling
MEA Metrics
MaxTwo
MaxTwo 6-Well Plate
Patch Clamp
Neuronal Cell Cultures
Svenja Kristin Tetzlaff, Ekin Reyhan, C. Peter Bengtson, Julian Schroers, Julia Wagner, Marc Cicero Schubert, Nikolas Layer, Maria C. Puschhof, Anton J. Faymonville, Nina Drewa, Rangel L. Pramatarov, Niklas Wissmann, Obada Alhalabi, Alina Heuer, Nirosan Sivapalan, JoaquÍn Campos, Berin Boztepe, Jonas G. Scheck, Giulia Villa, Manuel Schröter, Felix Sahm, Karin Forsberg-Nilsson, Michael O. Breckwoldt, Claudio Acuna, Bogdana Suchorska, Henrik Dieter Heiland, Julio Saez-Rodriguez, Varun Venkataramani
Download Resource
Access Resource
Back

Abstract

Details

Glioblastomas are heterogeneous brain tumors, notorious for their invasive behavior and resistance to therapy. Neuron-to-glioma synapses have been identified to promote glioblastoma invasion and proliferation. However, a comprehensive characterization of tumor-connected neurons has been hampered by a lack of technologies. Here, we adapted retrograde tracing with a modified rabies virus system to characterize and manipulate connected neuron-tumor networks. Glioblastoma rapidly integrated into neural circuits across the brain engaging in widespread functional communication, with acetylcholinergic and glutamatergic neurons driving glioblastoma progression. We uncovered patient-specific and tumor cell state-dependent differences in synaptogenic gene expression driving neuron-tumor connectivity and subsequent invasivity. Importantly, radiotherapy enhanced neuron-tumor connectivity by increased neuronal activity. In turn, simultaneous inhibition of AMPA receptors and radiotherapy showed increased therapeutic effects, indicative of a role for neuron-to-glioma synapses in contributing to therapeutic resistance. Lastly, rabies-mediated genetic ablation of tumor-connected neurons halted glioblastoma progression, offering a novel viral strategy to target glioblastoma. Together, this study provides a comprehensive framework for basic research and clinical translation of synaptic neuron-cancer interactions to target glioblastoma.